Bronchial Asthma: Clinical Trials

5 trials for Bronchial Asthma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Unknown 5
Phase 31Unknown 1

Follow Bronchial Asthma: new trials by email Literature Review of Bronchial Asthma trials Research Report on Bronchial Asthma

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study on the Prevention of Mild to Moderate Intermittent Asthma With Chinese Medicine Weiyang Yuping Fang
Weiyang Yuping Fang - Bronchial Asthma
Phase 2UnknownShanghai University of Traditional Chinese Medicine842020-10-012023-05-25
Clinical Study on Treatment of Chronic Persistent Bronchial Asthma
Ke Chuan Liu Wei Granule, Yang He Ping Chuan Granule, Ke Chuan Liu Wei Granule placebo - Bronchial Asthma
Phase 2UnknownShanghai University of Traditional Chinese Medicine3202018-02-012023-05-25
A Study to Assess Jia Wei Yang He Formula as a Plus Therapy in the Treatment of Persistent Asthma
Jia Wei Yang He granule, Jia Wei Yang He granule Placebo - Bronchial Asthma
Phase 2UnknownShanghai University of Traditional Chinese Medicine2402017-10-012024-05-07
Study on the Treatment of Bronchial Asthma With Traditional Chinese Medicine
Ke Chuan Liu Wei Mixture, Chuan Xiong Ping Chuan Mixture, Xie Wu Capsule - Bronchial Asthma
Phase 2UnknownShanghai University of Traditional Chinese Medicine2882017-07-302020-02-26
Omalizumab in Non-atopic Asthma
Omalizumab, Placebo - Bronchial Asthma
Phase 2 / Phase 3UnknownKing's College London402010-04-012011-01-21

Narrower conditions

Asthma (5)  ·  Hypersensitivity (1)

Broader conditions

Bronchial Diseases (5)  ·  Hypersensitivity, Immediate (5)  ·  Immune System Diseases (5)  ·  Lung Diseases (5)  ·  Lung Diseases, Obstructive (5)  ·  Respiratory Hypersensitivity (5)  ·  Respiratory Tract Diseases (5)  ·  Hypersensitivity (4)

Interventions

Omalizumab (1)

Sponsors

Shanghai University of Traditional Chinese Medicine (4)  ·  King's College London (1)

Countries

China (4)  ·  United Kingdom (1)

Top investigators

Zhenhui Lu, Doctor (2)  ·  Christopher Corrigan, MD, PhD (1)  ·  Huiyong Zhang, Director (1)  ·  Huiyong Zhang, Master (1)  ·  Neil Barnes, MD (1)  ·  Prathap Pillai, MD (1)

Results publications

PMID 27824606, PMID 29973284

NIH funding

2009 (1)